Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PROTAC CDK9 degrader-6 is a specific PROTAC targeting CDK9 that mediates its degradation through the proteasome pathway. This compound effectively degrades CDK9 with DC50 values of 0.10 μM and 0.14 μM for the CDK9 42 and CDK9 55 isoforms, respectively [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | PROTAC CDK9 degrader-6 is a specific PROTAC targeting CDK9 that mediates its degradation through the proteasome pathway. This compound effectively degrades CDK9 with DC50 values of 0.10 μM and 0.14 μM for the CDK9 42 and CDK9 55 isoforms, respectively [1]. |
Targets&IC50 | CDK9 55:0.05 μM (DC50), CDK9 42:0.03 μM (DC50) |
In vitro | PROTAC CDK9 degrader-6 (compound 16) (1 μM; 6 hours) reduces the protein levels of MCL2 and induces competitive degradation of CDK9 in MV411 cells [1]. Furthermore, PROTAC CDK9 degrader-6 (1 μM; 1-6 hours) diminishes the protein levels of MCL2 and CDK9 in a time-dependent manner, maintaining inhibition for 24 hours [1]. |
Molecular Weight | 878.8 |
Formula | C42H49Cl2N9O8 |
CAS No. | 2935587-91-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PROTAC CDK9 degrader-6 2935587-91-8 Cell Cycle/Checkpoint CDK inhibitor inhibit